Search - tctmd.com

Displaying 561 - 580 of 1670

Sort: Relevancy | Date

High-Sensitivity Troponin Tests Still Useful in Patients With Renal Dysfunction and Suspected ACS, With Caveats

News Daily News

High-Sensitivity Troponin Tests Still Useful in Patients With Renal Dysfunction and Suspected ACS, With Caveats

Yael L. Maxwell

October 06, 2017

TCTMD’s Top 10 Most Popular Stories for September 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2017

September 30, 2017

FDA Grants HeartWare LVAD a Destination Therapy Indication

News Daily News

FDA Grants HeartWare LVAD a Destination Therapy Indication

September 28, 2017

As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging

News Conference News PCR London Valves 2017

As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging

September 26, 2017

Pulmonary Artery Injury More Likely With Real-World Use of CardioMEMS, Analysis Suggests

News Daily News

Pulmonary Artery Injury More Likely With Real-World Use of CardioMEMS, Analysis Suggests

September 19, 2017

Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life

News Daily News

Frail Patients Benefit From MitraClip, With Gains in Function and Quality of Life

Michael O'Riordan

September 18, 2017

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

News Conference News VIVA 2017

ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA

September 15, 2017

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

No More Absorb BVS: Abbott Puts a Stop to Sales

News Daily News

No More Absorb BVS: Abbott Puts a Stop to Sales

September 08, 2017

ESC Algorithm for Rapidly Diagnosing NSTEMI Works, Study Confirms

News Conference News ESC 2017

ESC Algorithm for Rapidly Diagnosing NSTEMI Works, Study Confirms

September 08, 2017

TCTMD’s Top 10 Most Popular Stories for August 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2017

August 31, 2017

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

News Conference News ESC 2017

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

August 30, 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

August 27, 2017

Closing the Mitral Gap: Early Pascal Experience Shows Promise for High-Risk MR Patients

News Daily News

Closing the Mitral Gap: Early Pascal Experience Shows Promise for High-Risk MR Patients

Yael L. Maxwell

August 22, 2017

Boston Scientific Scraps Biodegradable Scaffold Program

News Daily News

Boston Scientific Scraps Biodegradable Scaffold Program

Michael O'Riordan

August 01, 2017

News Industry News

Abbott Initiates Clinical Trial of Three-Month Dual Antiplatelet Therapy Following Implantation with XIENCE Coronary Stent

July 25, 2017

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

News Daily News

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

July 21, 2017

ABSORB II Substudy Digs Into Long-term Arterial Remodeling Following BRS, DES Implantation

News Daily News

ABSORB II Substudy Digs Into Long-term Arterial Remodeling Following BRS, DES Implantation

Yael L. Maxwell

June 29, 2017

US Lawmakers Urged India to Rethink Stent Price Cap Ahead of State Visit

News Daily News

US Lawmakers Urged India to Rethink Stent Price Cap Ahead of State Visit

June 27, 2017

‘Mishmash’ of Troponin Cutoffs Being Used to Diagnose MI

News Daily News

‘Mishmash’ of Troponin Cutoffs Being Used to Diagnose MI

June 23, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.